New Progress and Treatment Monitoring of Lipid-Regulating Drugs

您当前的位置：

首页 >

文章列表页 >

New Progress and Treatment Monitoring of Lipid-Regulating Drugs

更新时间：2022-10-08

|

- New Progress and Treatment Monitoring of Lipid-Regulating Drugs
- Vol. 21, Issue 6, Pages: 764-768(2021)
- 作者机构：
  
  1. 中国人民解放军总医院医疗保障中心药剂科派驻第七医学中心药品保障室
  2. 中国人民解放军总医院第二医学中心神经内科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.06.029
  CLC： R972.6
- Published：2021，
扫描看全文
YANG Yumin, YAO Jiarui. New Progress and Treatment Monitoring of Lipid-Regulating Drugs. [J]. 21(6):764-768(2021)
DOI：

YANG Yumin, YAO Jiarui. New Progress and Treatment Monitoring of Lipid-Regulating Drugs. [J]. 21(6):764-768(2021) DOI： 10.14009/j.issn.1672-2124.2021.06.029.

摘要

调节血脂药不仅能调节血脂水平

还可抗氧化、抗炎、抗应激和抑制血栓形成

稳定或缩小动脉粥样硬化斑块

减少脑卒中和心血管事件的发生

成为一、二级预防的重要手段。本文总结调节血脂药尤其是前蛋白转化酶枯草溶菌素9抑制剂的进展以及治疗中的药学监护要点。

Abstract

Lipid-regulating drugs can not only regulate lipid levels

but also has the effects of antioxidant

antiinflammatory

anti-stress and thrombosis inhibition

stabilize or shrink atherosclerotic plaques

reduce the occurrence of stroke and cardiovascular events

which become an important measure for primary and secondary prevention. This article summarizes the progress of lipid-regulating drugs

especially proprotein convertase subtilisin/kexin type 9 inhibitors

and the key points of pharmacological monitoring in treatment.

关键词

调节血脂药前蛋白转化酶枯草溶菌素9抑制剂他汀类药物肌毒性药学监护

Keywords

Lipid-regulating drugsProprotein convertase subtilisin/kexin type 9 inhibitorStatinsMuscle poisonPharmaceutical care

references

0

Views

68

下载量

0

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Articles

Systematic Review of Efficacy and Safety of Dantian Jiangzhi Pills Combined with Statins in the Treatment of Hyperlipidemia

Interaction Between Cyclosporine and Statins in the Treatment of Primary Nephrotic Syndrome

Analysis and Pharmaceutical Care of Hypertension Complicated with Proteinuria Induced by Anlotinib

Analysis of Anticoagulation Therapy for Patients with Acute Pulmonary Embolism and Exploration of Inpatient Pharmaceutical Care Mode

Allergic Reactions Induced by Statins

Related Author

WU Yang

CUI Jie

FAN Zongjing

LI Xingxing

LIU Wei

GUO Heng

SONG Yao

YANG Hongge

Related Institution

Dept.of Cardiology, Dongfang Hospital, Beijing University of Chinese Medicine

Second School of Clinical Medicine, Beijing University of Chinese Medicine

Dept. of Pharmacy, Beijing Friendship Hospital Affiliated to Capital Medical University

Dept.of Oncology,People’s Hospital of Shandong Guangrao County

Dept. of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University

⁰